Member Info for TWatcher

I see the next big thing is the £8B Tender, I guess there's several days worth of ramping in that.

many listen...few admit...some namecall..none argue the points.

good to see no counter arguments that everything up until this point has been faff, the board has been the ODX "false dawn" gathering place. The literally thousands of ramper posts have been pointless, except perhaps to suck some poor guys in at higher prices whilst many merry day trade at their cost.

Wait until gov starts talking about Mass LFTs
April 1st, 2M a week
Announcement of gov bidstat for antigen testing...the life changing announcement.
TT completion of mologic by end of Feb (april and counting)
Feb 17th RTC antibody unleashing day
Vaccine rollout
3B+ demand for RTC test
UK gov contract for the RTC antibody test
CE of the visitect antibody test

A reverse timeline of the various milestones over the last 7+ months, each of which was proported to be the surefire catalyst for the next step up in ODX SP, from £3 to £13.67, depending of which particular ramper floats your boat.

All that fluff and faff, the SP still remains in basically the same range.

Orders, purchase orders, as the ceo stated on the 26th of March, is what will drive shareholder value for this manufacturing company. He was of course stating the obvious and what I've been saying for months. Believe the ceo when he said it, or don't believe anything he says, its your choice.

Meanwhile, since the beginning of Nov, 3.7M share options have been cashed in by directors and other employees, and in the same period of time not a single director bought shares except for Colin King who bought 35K shares. This life changing message appears not to have caught fire with the directors.

What matters to any manufacturing business are real purchase orders, this is what delivers value to shareholders.

Source, Colin king, 26/03/21.

you couldn't make it up, the chairman of the group funding Innova was born in Wuhan, and Innova was formed just in March last year.

just around the same time uk gov was faffing around forming the RTC, and several long establish uk companies were pinning their hopes on it and it's antibody tests, this company had an lft antigen test designed, validated and supplied to the uk since oct last year, and the most recent uk report says its extremely accurate. It's taken mologic longer to get its test validated, than it did for innov to start from nothing to get it into uk peoples mouths and noses. Something weird in all that.

"planning to expand to the UK."...is worrying.

The PM just said the words LFT and test about a dozen times, LFT news in every paper, news report, every carrier pigron in the country had a note with 'LFT' attached to its leg.

BJ tries his best by inventing 2nd largest LFT supplier in Europe. Other usual suspects try to whip up a frenzy, better get in now, no chance of getting in below £1 now...rampy crap.

Every couple of hrs the amount of tests the UK/England/Wolf76 needs increases, by lunchtime UK will need 1B tests a day.
Everyone seems to forget that PA consulting was tasked with ramping UK production to 2M a day, not 100M/135M/pick your crazy number of choice a week. ODX is ramping to 1/7th of that, but let that not interfer with good ole BJs 2nd largest LFT supplier in Europe, wrld exclusive.

So with an entire 4 days of endless ramping, and all that pent up demand, the SP is simply back to its same range as its been FOR MONTHS.

Unsurprisingly, SP stability over that time matches the stability of orders

Can the usual suspects give it a rest, you're just getting yourselves all wound up for no reason. It's the arrival of purchase orders, or the continued absence of them that drive the SP of any manufacturing company, and ODX is no different.

And you can't get an order for something that you can't make, ODX currently can't make any antigen LFTs. The longer it goes on without the uk gov picking Mologic test (which Mologic and GAD have been in a position to make since the end of 2020), the more likely it is that odx will have to start another TT process. I hope that isn't the case.

Rarely has anyone argued the facts of my posts. Often names are called

On this board, uncomfortable facts (like ODX can not sell a single antigen LFT at this time) is deramping.

"What is the obsession with BigJock from all you derampers?"

Dunno, but plenty here seem to hang on his every unverified word.

He proports to have frequent direct communications with the CEO, 'bestows' us with apparently direct quotes from the CEO. He also spouts absolute nonsense such as ODX on track to become 2nd biggest LFT supplier in Europe, and that there is some mystical life-changing announcement coming soon (or maybe its' been and gone, seems to have gone quiet on that one), whilst directors sell millions of shares.

To speak for yourself is one thing, to proport to be a communications conduit for the CEO, and then say things that are provable as incorrect, is something else altogether.

100M a week.....but...but..but.... that can't be right, ODX can only make 2M a week (and currently can make zero antigen LFTs) and we have it from big jock that ODX are on track to become the 2nd biggest LFT supplier in Europe, where are these other 98M a week coming from ???

Some of recent stuff on this board has been straight from the ramperville handbook, and no surprises as to who has been the main culprit.

Q. Is Alva currently producing anything, what is it and in what quantity?

A. We are producing all the tests...

Note "What quantities" was asked , but no quantities in the answer...which is the only thing, and I repeat the ONLY thing that matters for a manufacturing company.

26th of March via ODX tweet
"The TT process will conclude in due course"

we await for "due coruse"

"word on the street" ?
coranation street ?

"they must now be ready and mass producing"

I'm not sure who "they" are in this context, but CEO of ODX said no more recently than last week that he was unaware which test uk gov would select. In terms of the Mologic test, ODX isn't quite finished transferring it from Mologic.

ODX doesn't have an antigrn LFT

Positive antibody is proof of some sort of immunity, or the person is in the approx 1-3 people who have no symptoms or very mild symptoms, but can pass the virus onto others.

Good for monitoring antibody in the general population, crap on its own for determining whether someone is safe or not. there is a reason why the only application to date is surveillance.

Its a complicated issue.

1) Anegative antigen test only says you are negative on the day of the test.
2) Vaccination says you are 70-90% unlikely either to have covid or be a potential threat.
3) And antibody test suggests that you have some protect, depending on timing you could be asymptomatic but infectious ?

Not sure an antibody test is useful in ANY scenario for reducing infection.

For entry to an event, a properly administered antigen test is probably the best.

For travel, vaccination + test likely going to be the required combo.

cut n paste messed up, the quote was supposed to be "So there are bigger manufacturers out there - that is not news"

"Surely with 4 days break the chances that something will be released is massive never mind a possible leak."

The salient point is that BJ stated something that is patently and easily proved to be incorrect, ODX is clearly NOT on course to be the 2nd largest LFT manufacturer in Europe. Now ask yourself how much weight you should put into his many many other claims that by their nature can not so easily be challenged, terms such as life changing, or silver bullet etc.

"Everyone in the country has had a cold"

Actually the number of colds and flus have fallen dramatically over the last 12 months, due to mask wearing and hand washing, but never let facts get in the way of a good ramp.

"2nd Largest LFT manufacturer in Europe "

ODX are scaling up to 104M a year capacity, and according to the forcast back in OCT, should be there now. No further scale up numbers have been suggested.

GAD are scaling up to 250M LFT a year
https://uk.linkedin.com/in/joe-fitchett-a1890056

Abindgon are scaling up to 150M units a year
https://uk.advfn.com/stock-market/london/abingdon-health-ABDX/share-news/Abingdon-Health-PLC-Interim-Results/84526673

ODX got by far the smallest of the 3 LFT published contracts from uk Gov, specifically the maximum value of GAD contract is approximately x4 the max value of the ODX contract. surescreen contract is 33% more than ODX, GAD is increasing staff to well over 400.

They aren't even in the top 3 in the UK, and have announced in total 250K units of LFT production, AND NO OTHER PRODUCTION NUMBERS !

The CEO sure does pick strange rampy bedfellows, happy to rattle of statements that crumble under even the mildest scrunity